Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Neuroimmunology

• Publication date

  2010-09-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jneuroim.2010.05.030PMID 20605229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• The influence of microglia on the pathogenesis of Parkinson's disease.

  2009cited by this paper
• MAPKAP kinase 2‐deficiency prevents neurons from cell death by reducing neuroinflammation – relevance in a mouse model of Parkinson’s disease

  2008cited by this paper
• Neuroprotective effects of novel phosphatidylglycerol‐based phospholipids in the 6‐hydroxydopamine model of Parkinson's disease

  2008cited by this paper
• Progress in Parkinson's disease-where do we stand?

  2008cited by this paper
• Formyl-methionyl-leucyl-phenylalanine–Induced Dopaminergic Neurotoxicity via Microglial Activation: A Mediator between Peripheral Infection and Neurodegeneration?

  2008cited by this paper
• Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

  2008cited by this paper
• Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease

  2008cited by this paper
• Mechanism of 6‐hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6‐hydroxydopamine‐induced degeneration of dopaminergic neurons

  2007cited by this paper
• Chronic microglial activation and progressive dopaminergic neurotoxicity.

  2007cited by this paper
• Differential effects of GDF5 on the medial and lateral rat ventral mesencephalon.

  2007cited by this paper
• Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-kappaB and JNK activation and suppression of COX-2 activity.

  2007cited by this paper
• Journal of Neuroinflammation BioMed Central

  2007cited by this paper
• Blocking Soluble Tumor Necrosis Factor Signaling with Dominant-Negative Tumor Necrosis Factor Inhibitor Attenuates Loss of Dopaminergic Neurons in Models of Parkinson's Disease

  2006cited by this paper
• Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.

  2006cited by this paper
• Effects of 6‐hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line‐derived neurotrophic factor

  2004cited by this paper
• Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain.

  2004cited by this paper
• Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease

  2003cited by this paper
• Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

  2003cited by this paper
• Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide.

  2002cited by this paper
• A role for tumor necrosis factor alpha in death of dopaminergic neurons following neural transplantation.

  2002cited by this paper
• Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide

  2002cited by this paper
• Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid aspirin.

  2002cited by this paper
• In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain

  2002cited by this paper
• Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease

  2001cited by this paper
• Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

  2001cited by this paper
• Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons.

  2001cited by this paper
• Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons

  2001cited by this paper
• Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain

  2000cited by this paper
• Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro

  1999cited by this paper
• Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism.

  1999cited by this paper
• Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism

  1999cited by this paper
• Increase in level of tumor necrosis factor (TNF)-α in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic l-DOPA on the TNF-α induction

  1999cited by this paper
• Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons

  1999cited by this paper
• Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-alpha induction.

  1999cited by this paper
• Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease

  1998cited by this paper
• Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures.

  1995cited by this paper
• Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients.

  1994cited by this paper
• Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients

  1994cited by this paper
• Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients

  1994cited by this paper
• Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

  1994cited by this paper
• Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

  1994cited by this paper
• The new stereological methods for interpreting functional morphology from slices of cells and organs

  1991cited by this paper
• Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture

  1990cited by this paper
• Microglial response to 6-hydroxydopamine-induced substantia nigra lesions.

  1989cited by this paper
• Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

  1988cited by this paper
• Visualization and characterization of interleukin 1 receptors in brain.

  1987cited by this paper

• An update on the involvement of inflammatory mediators in Parkinson’s disease pathogenesis

  2025cites this paper
• Low-grade chronic inflammatory stimulation alleviates α‑syn accumulation in Parkinson's disease by activating autophagy to promote neuronal survival in the Thy1-h[A30P]α-syn mouse model.

  2025cites this paper
• The Role of Dysregulated Neuroinflammatory Molecular Pathways in Parkinson Disease: A Systematic Review

  2024cites this paper
• The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology

  2024cites this paper
• The role of ACE2 in RAS axis on microglia activation in Parkinson's disease.

  2024cites this paper
• SARS-CoV-2 envelope protein triggers depression-like behaviors and dysosmia via TLR2-mediated neuroinflammation in mice

  2023cites this paper
• Cytokine activity in Parkinson’s disease

  2023cites this paper
• Physical activity in a swimming pool attenuates memory impairment by reducing glutamate and inflammatory cytokines and increasing BDNF in the brain of mice with type 2 diabetes.

  2023cites this paper
• SARS-CoV-2 Envelope protein triggers depression and dysosmia via TLR2 mediated neuroinflammation

  2023cites this paper
• Movement Disorder and Neurotoxicity Induced by Chronic Exposure to Microcystin-LR in Mice

  2022cites this paper
• Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease

  2022cites this paper
• The Role of Epigenetics in Neuroinflammatory-Driven Diseases

  2022cites this paper
• Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review

  2022cites this paper
• Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.

  2022cites this paper
• Inflammatory cytokines TNFα, IL-1β, and IL-6 are induced in endotoxin- stimulated microglia through different signaling cascades

  2021cites this paper
• Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications

  2020cites this paper
• Cannabidiol modulates the expression of neuroinflammatory factors in stress‐ and drug‐induced reinstatement of methamphetamine in extinguished rats

  2020cites this paper
• P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD

  2020cites this paper
• Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death

  2019cites this paper
• Treg Cells Attenuate Neuroinflammation and Protect Neurons in a Mouse Model of Parkinson’s Disease

  2019cites this paper
• Innate immune signaling in the ventral tegmental area contributes to drug-primed reinstatement of cocaine seeking.

  2018cites this paper
• Involvement of Innate and Adaptive Immunity in Parkinson's Disease

  2017cites this paper
• Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia

  2017cites this paper
• Deciphering variability in the role of interleukin-1β in Parkinson’s disease

  2016cites this paper
• Toll-Like Receptor 4 Deficiency Causes Reduced Exploratory Behavior in Mice Under Approach-Avoidance Conflict

  2016cites this paper
• Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice

  2016cites this paper
• 14 Analysis of the Impact of CD 200 on Neurodegenerative Diseases

  2016cites this paper
• In vitro anti-neuroinflammatory and neuritogenic stimulatory effects of a medicinal mushroom lignosus rhinocerotis (Cooke) ryvarden / Syntyche Seow Ling Sing

  2016cites this paper
• Contributions of central and systemic inflammation to the pathophysiology of Parkinson ’ s disease

  2016cites this paper
• Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease

  2015cites this paper
• Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.

  2015cites this paper
• The Omega-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid (DHA) Reverses Corticosterone-Induced Changes in Cortical Neurons

  2015cites this paper
• Expanding the Xenobiotic Hypothesis of Drug Reward and Reinforcement: Implications of TLR4 Dependent Cocaine and Methamphetamine Induced Neuroinflammation on Reward, Relapse, Priming, and Neurotoxicity

  2015cites this paper
• Involvement of nitric oxide in the induction of interleukin-1 beta in microglia.

  2015cites this paper
• An examination of the impact of dietary lipids on behaviour and neurochemistry

  2015cites this paper
• Investigating the developmental and behavioral consequences of maternal immune activation on affected offspring

  2015cites this paper
• DAT isn’t all that: cocaine reward and reinforcement requires Toll Like Receptor 4 signaling

  2014cites this paper
• Drug Abuse Takes a Toll: Toll-Like Receptor 4 Signaling is Required for the Rewarding and Reinforcing Effects of Opioids, Cocaine, and Methamphetamine

  2014influential citation
• Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.

  2013cites this paper
• Parkinson's disease in the nuclear age of neuroinflammation.

  2013cites this paper
• Green tea polyphenols prevent Parkinson's disease: in vitro and in vivo studies

  2013cites this paper
• Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 as a Neuroprotective Agent: Promotion of the Morphological Development of Midbrain Dopaminergic Neurons

  2013influential citation
• LRRK-2 as a Key Molecule Bridging Inflammation to Parkinson's Disease

  2013cites this paper
• Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro.

  2013cites this paper
• Parkinson's disease in the nuclear age

  2013cites this paper
• Nicotine protects dopaminergic neurons against lipopolysaccharide-induced damage through a 7 nAChRs in microglia

  2013cites this paper
• Microglia-derived proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta induce Purkinje neuronal apoptosis via their receptors in hypoxic neonatal rat brain

  2012cites this paper
• GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia.

  2012cites this paper
• Exposure of foetal neural progenitor cells to IL‐1β impairs their proliferation and alters their differentiation – a role for maternal inflammation?

  2012cites this paper
• Inflammation in Parkinson’s Disease: Causes and Consequences

  2012influential citation
• Diagnostics, rehabilitation and models of Parkinson’s disease

  2012cites this paper
• Histamine modulates nitric oxide release by microglia and dopaminergic neuronal survival

  2012cites this paper
• Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System

  2012cites this paper
• Microglia activation-induced mesencephalic dopaminergic neurodegeneration — an in vitro model for Parkinson’s disease

  2012cites this paper
• Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.

  2012cites this paper
• TLR-4-Dependent and -Independent Mechanisms of Fetal Brain Injury in the Setting of Preterm Birth

  2012cites this paper
• Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?

  2012cites this paper
• Analysis of the Impact of CD200 on Neurodegenerative Diseases

  2011cites this paper
• D-β-hydroxybutyrate inhibits microglial activation in a cell activation model in vitro

  2011cites this paper
• Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence

  2011cites this paper
• Immunological responses of astroglia in the rat brain under acute stress: interleukin 1 beta co-localized in astroglia.

  2011cites this paper
• Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts

  2011cites this paper
• Evidence that the marine‐derived multi‐mineral aquamin has anti‐inflammatory effects on cortical glial‐enriched cultures

  2011cites this paper